Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 62,61
Quantité disponible : 9 disponible(s)
Ajouter au panierEtat : New.
Vendeur : INDOO, Avenel, NJ, Etats-Unis
EUR 64,99
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New.
Vendeur : Basi6 International, Irving, TX, Etats-Unis
EUR 70,95
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Vendeur : Books Puddle, New York, NY, Etats-Unis
EUR 68,60
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. pp. 272.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
EUR 70,89
Quantité disponible : 9 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : Majestic Books, Hounslow, Royaume-Uni
EUR 67,42
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. pp. 272.
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
EUR 67,47
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. pp. 272.
Langue: anglais
Edité par John Wiley and Sons Ltd, Hoboken, 2019
ISBN 10 : 111994077X ISBN 13 : 9781119940777
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
EUR 84,63
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : new. Paperback. AN AUTHORITATIVE SURVEY OF CURRENT RESEARCH INTO CLINICALLY USEFUL CONVENTIONAL AND NONCONVENTIONAL ANTIBIOTIC THERAPEUTICS Pharmaceutically-active antibiotics revolutionized the treatment of infectious diseases, leading to decreased mortality and increased life expectancy. However, recent years have seen an alarming rise in the number and frequency of antibiotic-resistant "Superbugs." The Centers for Disease Control and Prevention (CDC) estimates that over two million antibiotic-resistant infections occur in the United States annually, resulting in approximately 23,000 deaths. Despite the danger to public health, a minimal number of new antibiotic drugs are currently in development or in clinical trials by major pharmaceutical companies. To prevent reverting back to the pre-antibiotic erawhen diseases caused by parasites or infections were virtually untreatable and frequently resulted in deathnew and innovative approaches are needed to combat the increasing resistance of pathogenic bacteria to antibiotics. Bacterial Resistance to Antibiotics From Molecules to Man examines the current state and future direction of research into developing clinically-useful next-generation novel antibiotics. An internationally-recognized team of experts cover topics including glycopeptide antibiotic resistance, anti-tuberculosis agents, anti-virulence therapies, tetracyclines, the molecular and structural determinants of resistance, and more. Presents a multidisciplinary approach for the optimization of novel antibiotics for maximum potency, minimal toxicity, and appropriated degradabilityHighlights critical aspects that may relieve the problematic medical situation of antibiotic resistanceIncludes an overview of the genetic and molecular mechanisms of antibiotic resistanceAddresses contemporary issues of global public health and longevityIncludes full references, author remarks, and color illustrations, graphs, and charts Bacterial Resistance to Antibiotics From Molecules to Man is a valuable source of up-to-date information for medical practitioners, researchers, academics, and professionals in public health, pharmaceuticals, microbiology, and related fields. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 73,70
Quantité disponible : 2 disponible(s)
Ajouter au panierEtat : New.
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
EUR 78,25
Quantité disponible : 2 disponible(s)
Ajouter au panierEtat : As New. Unread book in perfect condition.
Vendeur : Ubiquity Trade, Miami, FL, Etats-Unis
EUR 96,30
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. Brand new! Please provide a physical shipping address.
Langue: anglais
Edité par John Wiley and Sons Ltd, 2019
ISBN 10 : 111994077X ISBN 13 : 9781119940777
Vendeur : Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlande
Edition originale
EUR 91,63
Quantité disponible : 15 disponible(s)
Ajouter au panierEtat : New. Num Pages: 400 pages. BIC Classification: PSAF. Category: (P) Professional & Vocational. Dimension: 246 x 189. . . 2019. 1st Edition. paperback. . . . .
Langue: anglais
Edité par John Wiley and Sons Ltd, 2019
ISBN 10 : 111994077X ISBN 13 : 9781119940777
Vendeur : Kennys Bookstore, Olney, MD, Etats-Unis
EUR 114,43
Quantité disponible : 15 disponible(s)
Ajouter au panierEtat : New. Num Pages: 400 pages. BIC Classification: PSAF. Category: (P) Professional & Vocational. Dimension: 246 x 189. . . 2019. 1st Edition. paperback. . . . . Books ship from the US and Ireland.
Langue: anglais
Edité par JOHN WILEY NP (ORIGINAL), 2019
ISBN 10 : 111994077X ISBN 13 : 9781119940777
Vendeur : UK BOOKS STORE, London, LONDO, Royaume-Uni
EUR 132,90
Quantité disponible : 3 disponible(s)
Ajouter au panierEtat : New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Langue: anglais
Edité par John Wiley and Sons Ltd, Hoboken, 2019
ISBN 10 : 111994077X ISBN 13 : 9781119940777
Vendeur : AussieBookSeller, Truganina, VIC, Australie
EUR 136,73
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : new. Paperback. AN AUTHORITATIVE SURVEY OF CURRENT RESEARCH INTO CLINICALLY USEFUL CONVENTIONAL AND NONCONVENTIONAL ANTIBIOTIC THERAPEUTICS Pharmaceutically-active antibiotics revolutionized the treatment of infectious diseases, leading to decreased mortality and increased life expectancy. However, recent years have seen an alarming rise in the number and frequency of antibiotic-resistant "Superbugs." The Centers for Disease Control and Prevention (CDC) estimates that over two million antibiotic-resistant infections occur in the United States annually, resulting in approximately 23,000 deaths. Despite the danger to public health, a minimal number of new antibiotic drugs are currently in development or in clinical trials by major pharmaceutical companies. To prevent reverting back to the pre-antibiotic erawhen diseases caused by parasites or infections were virtually untreatable and frequently resulted in deathnew and innovative approaches are needed to combat the increasing resistance of pathogenic bacteria to antibiotics. Bacterial Resistance to Antibiotics From Molecules to Man examines the current state and future direction of research into developing clinically-useful next-generation novel antibiotics. An internationally-recognized team of experts cover topics including glycopeptide antibiotic resistance, anti-tuberculosis agents, anti-virulence therapies, tetracyclines, the molecular and structural determinants of resistance, and more. Presents a multidisciplinary approach for the optimization of novel antibiotics for maximum potency, minimal toxicity, and appropriated degradabilityHighlights critical aspects that may relieve the problematic medical situation of antibiotic resistanceIncludes an overview of the genetic and molecular mechanisms of antibiotic resistanceAddresses contemporary issues of global public health and longevityIncludes full references, author remarks, and color illustrations, graphs, and charts Bacterial Resistance to Antibiotics From Molecules to Man is a valuable source of up-to-date information for medical practitioners, researchers, academics, and professionals in public health, pharmaceuticals, microbiology, and related fields. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.